Bertrand Velge - 02 Nov 2022 Form 4 Insider Report for LifeMD, Inc. (LFMD)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
31 Aug 2023, 19:00:10 UTC
Prior SEC filing
19 Oct 2022
Next SEC filing
30 Jan 2023
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Bertrand Velge

Key filing fact

Bertrand Velge filed Form 4 for LifeMD, Inc. (LFMD) on 31 Aug 2023.

Key facts

  • This page summarizes Bertrand Velge's Form 4 filing for LifeMD, Inc. (LFMD).
  • 4 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 31 Aug 2023, 19:00.

Change

  • Previous filing in this sequence was filed on 19 Oct 2022.
  • Current net transaction value: +$501,018.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

LFMD transaction

Common Stock

Award

Transaction value
$0
Shares
+10,000
Change %
+1.1%
Price
$0.000000
Shares after
926,666
Date
22 Nov 2022
Ownership
By Aliunde Ltd.
Footnotes
F1
LFMD transaction

Common Stock

Purchase

Transaction value
$114,818
Shares
+32,072
Change %
+15%
Price
$3.58
Shares after
249,482
Date
29 Aug 2023
Ownership
By Mascot Capital Management, LLC
Footnotes
F2
LFMD transaction

Common Stock

Purchase

Transaction value
$150,400
Shares
+40,000
Change %
+16%
Price
$3.76
Shares after
289,482
Date
30 Aug 2023
Ownership
By Mascot Capital Management, LLC
LFMD transaction

Common Stock

Purchase

Transaction value
$235,800
Shares
+60,000
Change %
+21%
Price
$3.93
Shares after
349,482
Date
31 Aug 2023
Ownership
By Mascot Capital Management, LLC
Footnotes
F3
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

The grant of restricted shares vested incrementally on December 31, 2022 (50%), March 31, 2023 (25%), and June 16, 2023 (25%).

Footnote F2

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.54 to $3.60, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the numbers of shares purchased at each separate price with the ranges set forth.

Footnote F3

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.86 to $3.99, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the numbers of shares purchased at each separate price with the ranges set forth.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .